Navigating Japan's COVID-19 Vaccination Challenges: A Shift in Legal Classification and the Opt-out System.
JMA J
; 7(1): 106-108, 2024 Jan 15.
Article
en En
| MEDLINE
| ID: mdl-38314429
ABSTRACT
On January 20, 2023, the Japanese government announced easing the legal handling of the novel coronavirus disease 2019 (COVID-19) under its Infectious Diseases Control Act, effective May 8, 2023. While free vaccines will continue in fiscal year 2023, the future of mass vaccinations remains uncertain. The opt-out system, wherein local governments schedule vaccinations on behalf of the residents, may potentially alleviate issues associated with the currently adopted opt-in approach, such as procedural intricacies and scheduling difficulties, thereby facilitating the recovery of vaccination rates and simultaneously addressing vaccine wastage concerns. Given that COVID-19 still presents a substantial risk to specific groups, such as the elderly, recognizing the benefits of the opt-out system and the ethical and geographical challenges it poses is essential. With the collaboration of local governments and healthcare institutions, ongoing surveillance and scientific assessment are indispensable.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Aspecto:
Ethics
Idioma:
En
Revista:
JMA J
Año:
2024
Tipo del documento:
Article
País de afiliación:
Japón
Pais de publicación:
Japón